Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Extension
NCT01775137Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of tobramycin in cystic fibrosis (CF), sponsored by Novartis. Started Feb 2013; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01775137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01775137.